SETD2 and nonpapillary renal cell carcinoma: A recent study has shown that SETD2 deficiency mediated reduction of H3K36me3 induced the recruitment of histone chaperone ASF1A/B and SPT16, increased MMP1 chromatin accessibility, and activated enhancers to drive genes involved in metastasis, promoted ccRCC metastasis (47).